Cargando…

Effect of finerenone on diabetic kidney disease outcomes with estimated glomerular filtration rate below 25 mL/min/1.73 m(2)

BACKGROUND: In the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease trial, finerenone reduced the risk of cardiovascular events in patients with chronic kidney disease (CKD) and type 2 diabetes, while in the Finerenone in Reducing Kidney Failure and Disease Pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mima, Akira, Lee, Rina, Murakami, Ami, Gotoda, Hidemasa, Akai, Ryosuke, Kidooka, Sayumi, Nakamoto, Takahiro, Kido, Suguru, Lee, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366575/ https://www.ncbi.nlm.nih.gov/pubmed/37497038 http://dx.doi.org/10.1016/j.metop.2023.100251

Ejemplares similares

Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m(2) or on Renal Replacement Therapy
por: Estiverne, Christopher, et al.
Publicado: (2020)

IgA Nephropathy with Macroproteinuria and a GFR of 20-30 ml/min/1.73 m(2) May Still Benefit from RAS Inhibition
por: Wang, Ying, et al.
Publicado: (2022)

Is it necessary to discontinue metformin in diabetic patients with GFR > 60 ml/min per 1.73 m(2) undergoing coronary angiography: A controversy still exists?
por: Namazi, Mohammad Hasan, et al.
Publicado: (2018)

High-normal albuminuria is associated with subclinical atherosclerosis in male population with estimated glomerular filtration rate ≥60 mL/min/1.73 m(2): A cross-sectional study
por: Kimura, Tomoe, et al.
Publicado: (2019)

Case Report: IgG4-related kidney disease complicated by interstitial pneumonia
por: Mima, Akira, et al.
Publicado: (2023)

Effects of incretin-based therapeutic agents including tirzepatide on renal outcomes in patients with type 2 diabetes: A systemic review and meta-analysis
por: Mima, Akira, et al.
Publicado: (2023)

Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m(2)): a proof-of-concept study
por: Donate-Correa, Javier, et al.
Publicado: (2023)

Changes in renal function over time in outpatients with eGFR ≥ 30 mL/min/1.73 m(2): implication for timing of renal function testing before contrast-enhanced CT imaging
por: Kuwatsuru, Yoshiki, et al.
Publicado: (2023)

A retrospective observational population‐based study to assess the prevalence and burden of illness of type 2 diabetes with an estimated glomerular filtration rate < 90 mL/min/1.73 m(2) in Ontario, Canada
por: Rapattoni, Wally, et al.
Publicado: (2021)

Association of Obesity and Kidney Function Decline among Non-Diabetic Adults with eGFR > 60 ml/min/1.73m(2): Results from the Multi-Ethnic Study of Atherosclerosis (MESA)
por: Malkina, Anna, et al.
Publicado: (2013)

Is There a Nonlinear Relationship between Serum Uric Acid and Lipids in a Hypertensive Population with eGFR ≥30 ml/min/1.73 m(2)? Findings from the China Hypertension Registry Study
por: Yu, Yu, et al.
Publicado: (2020)

Decreased cortical thickness, as estimated by a newly developed ultrasound device, as a risk for vertebral fracture in type 2 diabetes mellitus patients with eGFR of less than 60 mL/min/1.73 m(2)
por: Mishima, T., et al.
Publicado: (2014)

Mortality Rates Across 25-Hydroxyvitamin D (25[OH]D) Levels among Adults with and without Estimated Glomerular Filtration Rate <60 ml/min/1.73 m(2): The Third National Health and Nutrition Examination Survey
por: Kramer, Holly, et al.
Publicado: (2012)

Association between 24h Urinary Sodium and Potassium Excretion and Estimated Glomerular Filtration Rate (eGFR) Decline or Death in Patients with Diabetes Mellitus and eGFR More than 30 ml/min/1.73m(2)
por: Nagata, Takanobu, et al.
Publicado: (2016)

Superdeformation below N=73
por: Galindo-Uribarri, A, et al.
Publicado: (1996)

Cerebrospinal fluid biomarkers in patients with plasma HIV RNA below 20 copies/mL
por: Calcagno, Andrea, et al.
Publicado: (2014)

Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min
por: Yin, Ophelia, et al.
Publicado: (2021)

ADVANCED LIVER INJURY IN PATIENTS WITH CHRONIC HEPATITIS B AND VIRAL LOAD BELOW 2,000 IU/mL
por: de OLIVEIRA, Valter Oberdan Borges, et al.
Publicado: (2016)

Patterns of Hemodialysis Catheter Dysfunction Defined According to National Kidney Foundation Guidelines As Blood Flow <300 mL/min
por: Griffiths, Robert I., et al.
Publicado: (2011)

The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL
por: Antinori, Andrea, et al.
Publicado: (2014)

Temperature Change of Ophthalmic Viscosurgical Devices in a Bi-Chamber Set-Up at a Flow of 0 and 20mL/min
por: Jensen, Nathan R, et al.
Publicado: (2023)

The pyrochlore-type molybdate Pr(2)Mo(1.73)Sc(0.27)O(7)
por: Gall, Philippe, et al.
Publicado: (2012)

The Role of Finerenone in the Management of Diabetic Nephropathy
por: Veneti, Stavroula, et al.
Publicado: (2021)

Potassium management with finerenone: Practical aspects
por: Wanner, Christoph, et al.
Publicado: (2022)

Prostate cancer incidence in men with prostate‐specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer
por: Ola, Idris Olasunmbo, et al.
Publicado: (2022)

The decay of 33 min $^{104m}$Ag and 69 min $^{104g}$Ag
por: Münnich, F, et al.
Publicado: (1971)

The decay of 8 min $^{102m}$Ag and 13 min $^{102g}$Ag
por: Hnatowich, D J, et al.
Publicado: (1971)

Brain metabolism is significantly impaired at blood glucose below 6 mM and brain glucose below 1 mM in patients with severe traumatic brain injury
por: Meierhans, Roman, et al.
Publicado: (2010)

Cardiorenal benefits of finerenone: protecting kidney and heart
por: González-Juanatey, José R., et al.
Publicado: (2023)

The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone
por: Heinig, Roland, et al.
Publicado: (2023)

Individualizing Pharmacotherapy in Patients with Renal Impairment: The Validity of the Modification of Diet in Renal Disease Formula in Specific Patient Populations with a Glomerular Filtration Rate below 60 Ml/Min. A Systematic Review
por: Eppenga, Willemijn L., et al.
Publicado: (2015)

Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL
por: de la Peña, Amparo, et al.
Publicado: (2015)

Performance of 3 mL versus 5 mL Discarded Volume for Blood Sampling from Central Venous Access Device
por: Lalthanthuami, HT, et al.
Publicado: (2021)

Measurement of the kaon mass difference $m_L -m_S$ by the two regenerator method
por: Geweniger, C, et al.
Publicado: (1974)

Run 398M on 4.12.73
por: Tausch, L
Publicado: (1973)

M73. DRIVING ABILITIES IN PATIENTS WITH SCHIZOPHRENIA
por: Pardeller, Silvia, et al.
Publicado: (2020)

Safety Evaluation of Remdesivir for COVID-19 Patients with eGFR < 30 mL/min without Renal Replacement Therapy in a Japanese Single-Center Study
por: Umemura, Takumi, et al.
Publicado: (2022)

Nonsteroidal Mineralocorticoid Receptor Antagonist (Finerenone) in Cardiorenal Disease
por: Shah, Monarch, et al.
Publicado: (2023)

Nanoelectronic primary thermometry below 4 mK
por: Bradley, D. I., et al.
Publicado: (2016)

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
por: Lew, Mark F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mji9ddjvtb6dsuprglc436sno1